期刊文献+

胃癌中RhoC和CD44v6的表达及其临床意义 被引量:2

Expressions and Clinical Significance of RhoC and CD44v6 in Gastric Carcinoma
下载PDF
导出
摘要 背景与目的:探讨Ras相似蛋白C(Ras homologue C,RhoC)和CD44剪接变异体v6(CD44splice variant V6,CD44v6)在胃癌中的表达及其与临床病理因素之间的关系。材料与方法:采用免疫组化SP法检测97例胃癌组织中RhoC和CD44v6的表达情况。结果:97例胃癌组织中RhoC和CD44v6阳性率分别为77.31%(75/97)、83.50%(81/97),两者表达存在相关性(P<0.05)。RhoC和CD44v6表达均与胃癌的浸润深度和肿瘤分期有关(P<0.05),且淋巴结转移组RhoC表达显著高于无淋巴结转移组(P<0.05)。结论:RhoC和CD44v6蛋白的过量表达是胃癌的发生发展中的频发事件,可以作为判断预后的指标之一。 BACKGROUND AND AIM: To investigate the expressions of RhoC and CD44v6 proteins in gastric carcinoma (GC) and their relationship to clinicopathological factors. MATERLALS AND METHODS: Immunohistochemi staining SP method was used to evaluate the expressions of RhoC and CD44v6 in 97 cases of GC. RKSULTS: 75(77.31% ) and 81 (83.50%) of 97 cases showed overexpressions for RhoC and CD44v6, respectively. There was a significant correlation between the overexpression of RhoC and CD44v6 (P 〈 0.05) The expressions of RhoC and CD44v6 in GC were significantly associated with the depth of tumor invasion and TNM staging(P〈0.05) Moreover, the RhoC overexpression was associated with lymph node metastasis(P 〈 0.05). CONCLUSION: Overexpressions of RhoC and CD44v6 proteins are frequent events in GC. Measurement of these protein expressions might be used as a prognostic indicator for GC.
出处 《癌变.畸变.突变》 CAS CSCD 2008年第1期60-63,共4页 Carcinogenesis,Teratogenesis & Mutagenesis
基金 安徽省教育厅自然科学研究项目(2005kj378zc)
关键词 胃癌 RHOC CD44V6 侵袭 免疫组化 gastric carcinoma neoplasm RhoC CD44v6 invasion immunohistochemistry
  • 相关文献

参考文献11

二级参考文献24

  • 1Clark, Edwin A, Gloub TR, et al. Genomic analysis of metastasis reveals an essential role for RhoC[J]. Nature,2000,406 : 532.
  • 2Hiroshi, Ssiji S, Tatsushi K, et al. Genome wide analysis of gen expression in human hepatocellular carcinoma using cDNA microssary: Identification of gens involved in carcinogensis and tumor progression [J]. Cancer Res,2001,61:2129.
  • 3Horiuchi AI, Tsutomu Wang, Satoshi O,et al. Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma[J]. Laboratory Investigation, 2003,83 (6) : 861.
  • 4Narumiya S. The small GTPase Rho: cellular function and signal transduction[J]. Biochem, 1996,120 :215.
  • 5Kleer CG, Van G, Zhang Y, et al. Characterization of RhoC expression in benign and malignant breast disease:a potential new marker for small breast carcinomas with metastic ability[J]. Am J Pathol,2002,160(2) :579.
  • 6Lesley J.CD44 and its interaction with extracellular matrix[J].Adv Immunol,1993,54(4):271.
  • 7Yamamichi K,Uehara Y,Kitamura N,et al.Increased expression of CD44V6 mRNA significantly correlates with distant metastasis and poor prognosis in gastric cancer[J].Int J Cancer,1998,79(2):256.
  • 8Yanaguch A,Goi T,Yu-J,et al.Expression of CD44V6 in advanced gastric cancer and its relationship to hematogenous metastasis and long -term prognosis[J].J Surg oncol,2002,79(4):230.
  • 9Yamjaguchi A,Goi T.Clinical significance of combined immunohistochemical detection of CD44V6 and sialyl Lex expression for colorectal cancer patients undergoing curative resectioin[J].Oncology,1998,55(5):400.
  • 10Yao J,Xiong S,Klos K,et al.Multiple signaling pathways involved in activation of Matrix metal oproteinase-9(MMP-9) by heregulin-betal in human breast cancer cells[J].Oncogene,2001,20(56):8066.

共引文献37

同被引文献12

  • 1Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration: integrating signals from front to back. Science, 2003, 302 (5651) : 1704-1709.
  • 2Chen Y, Fu Z, Xu S, et al. The prognostic value of CD44 expression in gastric cancer: A meta-Analysis[J]. Biomed Pharmacother, 2014, 68(6): 693-710.
  • 3Zhmag Y, Zhang L, Zhmag G, et al. Osteosarcoma mesis: prospective role of ezrin[J]. Turnout Biol, 2014, 35(6): 5055- 5064.
  • 4Gschwantler-Kaulich D, Natter C, Steurer S, et al. Increase in ezrin expression from benign to malignant breast tumors[J]. Cell Oncol, 2013, 36(6): 485-491.
  • 5Oda Y, Aishima S, Morimatsu K, et al. Differential Ezrin and phosphorylated Ezrin expression profiles between pancreatic intraepithelial neopia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas[J]. Hum Pathol, 2013, 44(8): 1487-1498.
  • 6Chai L, Liu H, Zhang Z, et al. CDd4 expression is predictive of poor prognosis in pharyngolaryngeal cancer: systematic review and meta-analysis[J]. Tohoku J Exp Med, 2014, 232 (1): 9-19.
  • 7Joshua B, Kaplan M J, Doweck I, el al. Frequency of cells expressing CD44, a head and neck cancer stem cell marker: correlation with tumor aggressiveness[J]. Head Neck, 2012, 34(1): 42-49.
  • 8Jiang H, Zhao W, Shao W. Prognostic value of CD44 and CD44v6 expression in patients with non-small cell lung cancer: meta-analysis[J]. Tumor Biol, 2014, 35(8): 7383- 7392.
  • 9赵杨,徐惠绵.RhoC和Rho激酶在上皮性卵巢癌中的表达及临床意义[J].山东医药,2008,48(9):78-79. 被引量:3
  • 10张恒,蒋鹏程,陈锁成.胃癌综合治疗进展[J].中国实用医药,2008,3(29):182-184. 被引量:10

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部